Industry News
First burns patient treated in NovoSorb BTM trial
Calzada (ASX:CZD) revealed that the first burns patient enrolled in a clinical trial of its NovoSorb BTM has been successfully treated and is out of intensive care. [ + ]
Starpharma making progress with clinical trials
Starpharma (ASX:SPL) has dosed the first group of patients for a phase I trial of DEP docetaxel in solid tumours and commenced final preparations for a phase III trial of VivaGel for the prevention of BV recurrence. [ + ]
Macfarlane criticises Labor science policies
The Minister for Industry, Ian Macfarlane, has claimed that the former Labor government's science policies "made no provision for the ongoing costs of science and research", according to Senate estimates. [ + ]
The physics behind a World Cup soccer ball
A new soccer ball, the Brazuca, has been created for the 2014 FIFA World Cup. Physics experts from the University of Adelaide have described it is a 'keepers' ball', in contrast with the 2010 ball, the Jabulani. [ + ]
Research and innovation key to driving productivity
Innovation, science and research are key drivers of productivity and the building of future industries in Australia, says a report by The Australian Council of Learned Academies. [ + ]
ResMed wins import ban against Taiwan's APEX
An ITC judge has ruled that two products from Taiwanese manufacturer APEX still infringe on ResMed (ASX:RMD) patents and cannot be imported or sold in the US. [ + ]
Bellberry funds tropical health researchers
Five researchers from the Australian Institute of Tropical Health and Medicine (AITHM) at James Cook University (JCU) have received a $400,000 donation from research ethics company Bellberry. [ + ]
New guidance for ASX-listed companies
Two new guidance documents are now available to support ASX-listed companies. The third edition of the ASX's Corporate Governance Principles and Recommendations (CGPR) comes into effect on 1 July after a recent review, and ASIC has released guidance to ASX-listed entities on analyst and investor briefings. [ + ]
Immunotherapy shows promise in treating brain cancer
Combining standard treatment for recurrent glioblastoma multiforme with immune-based therapies holds promise for patients with this aggressive disease. [ + ]
DNA analysis on the go
A mobile app that analyses DNA sequences has been developed and made freely available by researchers in Singapore. [ + ]
Organ-on-chip pioneer to deliver 2014 Graeme Clark Oration
The 2014 Graeme Clark Oration, hosted by the ICT for Life Sciences Forum at the Melbourne Convention Centre, will be presented on 5 June by Wyss Institute founding director Dr Don Ingber. [ + ]
Manipulating stem cells to repair brain damage
A scientist from Queensland University of Technology (QUT) is hoping to unlock the potential of stem cells as a way of repairing neural damage to the brain. [ + ]
AusMedtech responds to the TGA's review of the low value turnover exemption scheme
AusMedtech has told the TGA's review that it is concerned that only a very low number of small businesses are taking advantage of the low value turnover exemption (LVT) scheme, despite the eligibility of their products. [ + ]
Synthetic yeast project a world first
Macquarie University will lead the Australian arm in a project aiming to create the first synthetic complex organism - yeast. [ + ]
CVac boosts OS in second-remission ovarian cancer
Data from a phase II trial of Prima BioMed's (ASX:PRR) CVac show that the treatment has had a positive effect on overall survival in ovarian cancer patients in second-line remission. [ + ]
